Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Prognostic Implications of Calculated Apo-Lipoprotein B in Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcome Is Tied to Lower Cut-Points
Mojtaba Salarifar
Mojtaba Salarifar

Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Center

Tehran Heart Research Center

Tehran University of Medical Sciences

All Documents
1. Impact of Cigarette Smoking on the Outcomes of St-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention in Metropolitan Tehran, Frontiers in Emergency Medicine (2024)
2. Comparative Outcomes of Percutaneous Transvenous Mitral Commissurotomy Between Low and High Wilkins Score, Asian Cardiovascular and Thoracic Annals (2023)
3. Comparison of 1-Year Follow-Up Echocardiographic Outcomes of Sapien 3 Versus Evolut R Bioprosthetic Transcatheter Aortic Valves: A Single-Center Retrospective Iranian Cohort Study, Critical Pathways in Cardiology (2023)
4. Evaluating the Role of Intravenous Pentoxifylline Administration on Primary Percutaneous Coronary Intervention Success Rate in Patients With St-Elevation Myocardial Infarction (Pentos-Pci), Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
5. Evaluation of the Causes of Door-To-Balloon Time Delays in Patients With St-Elevation Myocardial Infarction at Tehran Heart Center, Journal of Tehran University Heart Center (2023)
6. Extensive Cardiovascular Involvement in a Young Boy With Gaucher’S Disease: A Case Report, European Heart Journal - Case Reports (2023)
7. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
8. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
9. Comparison of Angiographic and Clinical Outcomes After Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction Between Patients With and Without Concomitant Covid-19 Infection, Critical Pathways in Cardiology (2022)
10. Effect of Minocycline on the Left Ventricular Function Following St-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention, Trials (2022)
11. Effect of Portable Air Purifier on Indoor Air Quality: Reduced Exposure to Particulate Matter and Health Risk Assessment, Environmental Monitoring and Assessment (2022)
12. Effect of Postoperative Atrial Fibrillation on Early and Mid-Term Outcomes of Coronary Artery Bypass Graft Surgery, European Journal of Cardio-thoracic Surgery (2022)
13. Health Benefits of Using Air Purifier to Reduce Exposure to Pm2.5-Bound Polycyclic Aromatic Hydrocarbons (Pahs), Heavy Metals and Ions, Journal of Cleaner Production (2022)
14. Impact of Baseline Estimated Glomerular Filtration Rate Using Ckd-Epi Equation on Long-Term Prognosis of Stemi Patients: A Matter of Small Increments!, Critical Pathways in Cardiology (2022)
15. In-Hospital and 1-Year Outcomes of Repeated Percutaneous Coronary Intervention for In-Stent Restenosis With Acute Coronary Syndrome Presentation, Critical Pathways in Cardiology (2022)
16. Outcome of Percutaneous Coronary Intervention in Old Patients Presenting With Acute Coronary Syndrome, Archives of Iranian Medicine (2022)
17. Predictors of In-Hospital Mortality in Diabetic Patients With Non-St-Elevation Myocardial Infarction, Egyptian Heart Journal (2022)
18. Relationship Between Severity and Complexity of Coronary Artery Involvement and Obstructive Sleep Apnea Based on Stop-Bang Questionnaire, International Journal of Preventive Medicine (2022)
19. Sex Difference in the Risk Factor Distributions and Outcomes After Coronary Artery Bypass Graft Surgery in the Young Population, European Journal of Cardio-thoracic Surgery (2022)
20. The Association Between Different Body Mass Index Levels and Midterm Surgical Revascularization Outcomes, PLoS ONE (2022)
21. Ventricular Repolarization Heterogeneity in Patients With Covid-19: Original Data, Systematic Review, and Meta-Analysis, Clinical Cardiology (2022)
22. 24/7 Primary Percutaneous Coronary Intervention As a National Program, Critical Pathways in Cardiology (2021)
23. Burden of Hypertensive Heart Disease in Iran During 1990-2017: Findings From the Global Burden of Disease Study 2017, PLoS ONE (2021)
24. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
25. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
26. Predicting the Outcome in Confirmed Covid-19 Patients With Coronary Artery Disease: A Key Role for the First Chest Computed Tomography, Egyptian Heart Journal (2021)
27. Prevalence and Trends of Coronary Artery Disease Risk Factors and Their Effect on Age of Diagnosis in Patients With Established Coronary Artery Disease: Tehran Heart Center (2005–2015), BMC Cardiovascular Disorders (2021)
28. Prognostic Implications of Calculated Apo-Lipoprotein B in Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcome Is Tied to Lower Cut-Points, Clinical Cardiology (2021)
29. Right Atrial Appendage Thrombosis in a Patient With a History of Myocardial Infarction, Journal of Cardiovascular Echography (2021)
30. Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome, Value in Health Regional Issues (2021)
31. Tehran Cohort Study (Tecs) on Cardiovascular Diseases, Injury, and Mental Health: Design, Methods, and Recruitment Data, Global Epidemiology (2021)
32. Comparison of Oral and Intravenous N-Acetyl Cysteine in Preventing Contrast Nephropathy, Indian Journal of Nephrology (2020)
33. Covid-19 Sends Stemi to Quarantine!?, Clinical Research in Cardiology (2020)
34. Does Baseline Bun Have an Additive Effect on the Prediction of Mortality in Patients With Acute Pulmonary Embolism?, Journal of Tehran University Heart Center (2020)
35. One-Year Outcome of Patients With Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks, Journal of Tehran University Heart Center (2020)
36. Relationship Between the Severity of Coronary Artery Disease and Cardiovascular Risk Factors in Acute Coronary Syndrome: Based on Tehran Heart Center’S Data Registry, Journal of Tehran University Heart Center (2020)
37. Safety of Thrombolytic Therapy in Patients With Prosthetic Heart Valve Thrombosis Who Have High International Normalized Ratio Levels, Journal of Cardiac Surgery (2020)
38. Short-Term Safety and Long-Term Benefits of Stent Postdilation After Primary Percutaneous Coronary Intervention: Results of a Cohort Study, Catheterization and Cardiovascular Interventions (2020)
39. The Impact of a Dedicated Coronavirus Disease 2019 Primary Angioplasty Protocol on Time Components Related to St-Segment Elevation Myocardial Infarction Management in a 24/7 Primary Percutaneous Coronary Intervention–Capable Hospital, Kardiologia Polska (2020)
40. Twelve-Year History of Stemi Management in Tehran Heart Center: Concomitant Reduction of In-Hospital Mortality and Hospitalization Length, Archives of Iranian Medicine (2020)
41. Cha2ds2-Vasc Score As an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality After Primary Pci in Patients With Acute St Segment Elevation Myocardial Infarction, Medicina (Lithuania) (2019)
42. Does Invasive Treatment Increase the Long-Term Survival of St-Elevation Myocardial Infarction Patients With a History of Coronary Artery Bypass Graft Surgery?, Journal of Tehran University Heart Center (2019)
43. Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry, Critical Pathways in Cardiology (2019)
44. Pre-Hospital Delay and Its Contributing Factors in Patients With St-Elevation Myocardial Infarction; a Cross Sectional Study, Archives of Academic Emergency Medicine (2019)
45. Single Long Stents Versus Overlapping Multiple Stents in the Management of Very Long Coronary Lesions: Comparisons of Procedures and Clinical Outcomes, Journal of Tehran University Heart Center (2019)
46. Strategies to Reduce the Door-To-Device Time in St-Elevation Myocardial Infarction Patients, Journal of Tehran University Heart Center (2019)
47. Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With St-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (Pci) According to the 24/7 Primary Pci Service Registry in Iran: Protocol for a Cross-Sectional Study, JMIR Research Protocols (2019)
48. Tubular Thrombus-In-Transit Detected Initially on Computed Tomography Scan, Turk Kardiyoloji Dernegi Arsivi (2019)
49. Angiographic Characteristics of St-Elevation Myocardial Infarction Patients With Infarct-Related Coronary Artery Ectasia Undergoing Primary Percutaneous Coronary Intervention, Critical Pathways in Cardiology (2018)
50. Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals, Archives of Iranian Medicine (2018)
51. Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2018)
52. Predictors of Long-Term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly, Archives of Iranian Medicine (2018)
53. Predictors of Major Adverse Cardiac Events Following Elective Stenting of Large Coronary Arteries, Indian Heart Journal (2018)
54. Protection From Reperfusion Injury With Intracoronary N-Acetylcysteine in Patients With Stemi Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center, American Journal of Cardiovascular Drugs (2018)
55. Two-Year Follow-Up of Patients With Unstable Angina/Non-St Segment Elevation Myocardial Infarction Undergoing Early Invasive Strategy: Predictors of Normal or Near-Normal Coronary Angiography and Mortality, Critical Pathways in Cardiology (2018)
56. Impact of Sex on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention, Critical Pathways in Cardiology (2017)
57. Initial Experiences of Transcatheter Aortic Valve Implantation (Tavi) in Iran With Midterm Follow Up, International Cardiovascular Research Journal (2017)
58. Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study, Texas Heart Institute Journal (2016)
59. Comparing Clinical Outcomes for a Twelve-Month Trial of Zotarolimus- and Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Data From the Thcric Registry, Therapeutic Advances in Cardiovascular Disease (2016)
60. Comparison of 1-Year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein Iib/Iiia Inhibitors, Critical Pathways in Cardiology (2016)
61. Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With St-Elevation Myocardial Infarction, American Journal of Therapeutics (2016)
62. One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2016)
63. The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and Hs-Crp Level in Patients With Venous Thromboembolism, Clinical and Applied Thrombosis/Hemostasis (2016)
64. A Risk-Scoring Model to Predict One-Year Major Adverse Cardiac Events After Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)
65. Percutaneous Aortic Valve Implantation in Bicuspid Aortic Valve: A Case Report, ARYA Atherosclerosis (2015)
66. Relationship Between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)
67. The Effect of Curcumin on Some of Traditional and Non-Traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial, Iranian Journal of Pharmaceutical Research (2015)
68. The Impact of Cytochrome P450 2C19 Polymorphism on the Occurrence of One-Year In-Stent Restenosis in Patients Who Underwent Percutaneous Coronary Intervention: A Case-Match Study, Anadolu Kardiyoloji Dergisi (2015)